"Mercaptoethylamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ethylamines, including CYSTEAMINE, that contain a sulfhydryl group in their structure.
| Descriptor ID |
D008624
|
| MeSH Number(s) |
D02.092.471.562 D02.886.489.472
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mercaptoethylamines".
Below are MeSH descriptors whose meaning is more specific than "Mercaptoethylamines".
This graph shows the total number of publications written about "Mercaptoethylamines" by people in this website by year, and whether "Mercaptoethylamines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 2 | 4 |
| 1999 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mercaptoethylamines" by people in Profiles.
-
Capizzi RL. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine. Semin Oncol. 1999 Apr; 26(2 Suppl 7):3-21.
-
List AF, Heaton R, Glinsmann-Gibson B, Capizzi RL. Amifostine protects primitive hematopoietic progenitors against chemotherapy cytotoxicity. Semin Oncol. 1996 Aug; 23(4 Suppl 8):58-63.
-
Capizzi R. Amifostine: the preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies. Semin Oncol. 1996 Aug; 23(4 Suppl 8):2-17.
-
Ryan SV, Carrithers SL, Parkinson SJ, Skurk C, Nuss C, Pooler PM, Owen CS, Lefer AM, Waldman SA. Hypotensive mechanisms of amifostine. J Clin Pharmacol. 1996 Apr; 36(4):365-73.
-
Alberts DS, Speicher LA, Krutzsch M, Wymer J, Capizzi RL, Conlon J, Barrett A, Aickin M. WR-1065, the active metabolite of amifostine (Ethyol), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells. Eur J Cancer. 1996; 32A Suppl 4:S17-20.